Source comparison
CJC-1295 Blood Work Labs: Protocol Comparison Table
Baseline (pre-protocol) IGF-1, fasting GH, AST/ALT, creatinine, glucose, HbA1c, prolactin Morning fasted, 48 hrs post-exercise Age-appropriate reference ranges Establish individual baseline. No intervention 4-Week Titration Check IGF-1, prolactin, AST/ALT 4–6
This comparison does not assign a generated winner or score.
- Baseline (pre-protocol)
- IGF-1, fasting GH, AST/ALT, creatinine, glucose, HbA1c, prolactin
- Morning fasted, 48 hrs post-exercise
- Age-appropriate reference ranges
- Establish individual baseline. No intervention
- 4-Week Titration Check
- IGF-1, prolactin, AST/ALT
- 4–6 weeks after reaching maintenance dose
- IGF-1 +40–80 ng/mL above baseline; prolactin <30 ng/mL (M), <35 ng/mL (F)
- IGF-1 <+20 ng/mL = dose increase or discontinue; prolactin >30/35 = add cabergoline or reduce dose
- 12-Week Sustained Response
- IGF-1, GH, AST/ALT, creatinine, glucose, HbA1c, prolactin, TSH, free T3/T4
- 12 weeks on protocol
- IGF-1 sustained +30–60 ng/mL; HbA1c <5.7%; AST/ALT <1.5× ULN
- IGF-1 return to baseline = cycle off 4–6 weeks; HbA1c >5.7% or glucose >100 mg/dL = metabolic intervention
- Long-Term Monitoring (6+ months)
- IGF-1, liver panel, kidney function, thyroid panel, fasting glucose
- Every 12–16 weeks
- Stable IGF-1 elevation without metabolic deterioration
- Any biomarker trending outside safe range = protocol adjustment or discontinuation